A detailed history of Allianz Asset Management Gmb H transactions in Catalent, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 9,902 shares of CTLT stock, worth $597,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,902
Previous 10,302 3.88%
Holding current value
$597,387
Previous $581,000 4.3%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $21,432 - $22,808
-400 Reduced 3.88%
9,902 $556,000
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $23,237 - $32,661
-546 Reduced 5.03%
10,302 $581,000
Q4 2023

Feb 12, 2024

SELL
$32.18 - $46.57 $19,211 - $27,802
-597 Reduced 5.22%
10,848 $487,000
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $551,306 - $626,144
-12,473 Reduced 52.15%
11,445 $521,000
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $13.4 Million - $28.2 Million
-419,244 Reduced 94.6%
23,918 $1.04 Million
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $47.8 Million - $78.2 Million
-1,052,567 Reduced 70.37%
443,162 $29.1 Million
Q4 2022

Feb 13, 2023

SELL
$41.39 - $81.0 $1.22 Million - $2.39 Million
-29,469 Reduced 1.93%
1,495,729 $67.3 Million
Q3 2022

Nov 08, 2022

SELL
$72.36 - $113.1 $15.6 Million - $24.4 Million
-215,984 Reduced 12.4%
1,525,198 $110 Million
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $13.4 Million - $17.5 Million
-153,493 Reduced 8.1%
1,741,182 $187 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $18.2 Million - $24 Million
192,915 Added 11.34%
1,894,675 $210 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $42.3 Million - $49.3 Million
354,170 Added 26.28%
1,701,760 $218 Million
Q3 2021

Nov 10, 2021

BUY
$109.17 - $142.35 $85 Million - $111 Million
778,781 Added 136.91%
1,347,590 $179 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $2.57 Million - $2.96 Million
25,618 Added 4.72%
568,809 $61.5 Million
Q1 2021

May 13, 2021

BUY
$101.51 - $125.27 $3.55 Million - $4.38 Million
34,955 Added 6.88%
543,191 $57.2 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $8.51 Million - $10.4 Million
99,133 Added 24.23%
508,236 $52.9 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $414,545 - $527,157
-5,699 Reduced 1.37%
409,103 $35 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $1.46 Million - $2.41 Million
-30,430 Reduced 6.83%
414,802 $30.4 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $2.11 Million - $3.6 Million
57,148 Added 14.73%
445,232 $23.1 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $5.19 Million - $6.24 Million
110,185 Added 39.65%
388,084 $21.8 Million
Q3 2019

Nov 13, 2019

SELL
$47.45 - $58.05 $597,680 - $731,197
-12,596 Reduced 4.34%
277,899 $13.2 Million
Q2 2019

Aug 08, 2019

SELL
$39.26 - $54.21 $802,121 - $1.11 Million
-20,431 Reduced 6.57%
290,495 $15.7 Million
Q1 2019

May 13, 2019

SELL
$29.84 - $43.92 $2.09 Million - $3.08 Million
-70,107 Reduced 18.4%
310,926 $12.6 Million
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $5.47 Million - $8.47 Million
-182,705 Reduced 32.41%
381,033 $11.9 Million
Q3 2018

Nov 13, 2018

SELL
$40.12 - $45.55 $2.81 Million - $3.19 Million
-70,080 Reduced 11.06%
563,738 $25.7 Million
Q2 2018

Aug 13, 2018

SELL
$38.72 - $42.52 $2.99 Million - $3.28 Million
-77,101 Reduced 10.85%
633,818 $26.6 Million
Q1 2018

May 14, 2018

BUY
$39.4 - $47.39 $79,627 - $95,775
2,021 Added 0.29%
710,919 $29.2 Million
Q4 2017

Feb 13, 2018

BUY
$37.27 - $43.02 $457,191 - $527,726
12,267 Added 1.76%
708,898 $29.1 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $9.24 Million - $11.4 Million
273,861 Added 64.78%
696,631 $27.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,714 Added 0.41%
422,770 $14.8 Million
Q1 2017

Apr 17, 2019

BUY
N/A
65,410 Added 18.39%
421,056 $11.9 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-2,015 Reduced 0.56%
355,646 $9.59 Million
Q3 2016

Apr 17, 2019

BUY
N/A
357,661
357,661 $9.24 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.